Intuitive Surgical (NASDAQ:ISRG) has released its fourth-generation robotic surgery machine, the da Vinci Xi. It's the first new product the company has released in a couple years, and in this video from Wednesday's Stock of the Day, Motley Fool analyst Simon Erickson tells investors why he thinks it could be a major driver for the stock.
Not only is this next-generation machine easier for surgeons to use, Simon also sees the da Vinci Xi as having a flexibility of motion that will enable the device to conduct a wider range of general surgery procedures. Intuitive's machines previously were somewhat limited on what they could handle, but Simon sees this new wider range of applications as the game changer.
But is the stock a buy at these prices? Simon still thinks so. Here he discusses what he loves about the company's management and its revenue, and why he continues to see it as a buy today.
Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion dollar industry." And the technology behind is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and it's ability to make life-changing medical solutions never thought possible. To learn how you can invest in this unbelievable new technology, click here now to see our free report.
Mark Reeth has no position in any stocks mentioned. Simon Erickson owns shares of Intuitive Surgical. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.